Mechanistically, CSRP2BP promotes the EMT process partly by increasing H4 acetylation via cooperation with SMAD4, resulting in the upregulation of N-cadherin and finally promoting the invasion, migration and chemoresistance of cervical cancer cells in vitro and the metastasis of cervical cancer in vivo. Here, CDH2 is linked to cervical cancer.